Salgia R - Search Results

1

Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.

Wood K, Hensing T, Malik R, Salgia R. Wood K, et al. Among authors: salgia r. JAMA Oncol. 2016 Jun 1;2(6):805-12. doi: 10.1001/jamaoncol.2016.0405. JAMA Oncol. 2016. PMID: 27100819 Review.

2

Molecular abnormalities in lung cancer.

Salgia R, Skarin AT. Salgia R, et al. J Clin Oncol. 1998 Mar;16(3):1207-17. doi: 10.1200/JCO.1998.16.3.1207. J Clin Oncol. 1998. PMID: 9508209 Review.

3

Molecular and cellular biology of small cell lung cancer.

Sattler M, Salgia R. Sattler M, et al. Among authors: salgia r. Semin Oncol. 2003 Feb;30(1):57-71. doi: 10.1053/sonc.2003.50019. Semin Oncol. 2003. PMID: 12635090 Review.

4

Targeted molecules in small cell lung cancer.

Murray N, Salgia R, Fossella FV. Murray N, et al. Among authors: salgia r. Semin Oncol. 2004 Feb;31(1 Suppl 1):106-11. doi: 10.1053/j.seminoncol.2003.12.021. Semin Oncol. 2004. PMID: 14981588 Review.

5

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K, Lader A, Richards W, Sugarbaker D, Husain AN, Christensen JG, Salgia R. Ma PC, et al. Among authors: salgia r. Cancer Res. 2005 Feb 15;65(4):1479-88. doi: 10.1158/0008-5472.CAN-04-2650. Cancer Res. 2005. PMID: 15735036

6

Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.

Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, Salgia R. Jagadeeswaran R, et al. Among authors: salgia r. Am J Physiol Lung Cell Mol Physiol. 2007 Jun;292(6):L1488-94. doi: 10.1152/ajplung.00147.2006. Epub 2007 Feb 23. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 17322284 Free article.

7

Novel targets for therapeutic agents in small cell lung cancer.

Ma PC, Salgia R. Ma PC, et al. Among authors: salgia r. J Natl Compr Canc Netw. 2004 Mar;2(2):165-72. doi: 10.6004/jnccn.2004.0014. J Natl Compr Canc Netw. 2004. PMID: 19777705 Review.

8

The role of EGFR inhibition in the treatment of non-small cell lung cancer.

Ray M, Salgia R, Vokes EE. Ray M, et al. Among authors: salgia r. Oncologist. 2009 Nov;14(11):1116-30. doi: 10.1634/theoncologist.2009-0054. Epub 2009 Nov 5. Oncologist. 2009. PMID: 19892771 Free article. Review.

9

The role of chemokine receptor CXCR4 in lung cancer.

Gangadhar T, Nandi S, Salgia R. Gangadhar T, et al. Among authors: salgia r. Cancer Biol Ther. 2010 Mar 15;9(6):409-16. doi: 10.4161/cbt.9.6.11233. Epub 2010 Mar 18. Cancer Biol Ther. 2010. PMID: 20147779 Free PMC article. Review.

10

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.

Ettinger DS, Jotte R, Lorigan P, Gupta V, Garbo L, Alemany C, Conkling P, Spigel DR, Dudek AZ, Shah C, Salgia R, McNally R, Renschler MF, Oliver JW. Ettinger DS, et al. Among authors: salgia r. J Clin Oncol. 2010 May 20;28(15):2598-603. doi: 10.1200/JCO.2009.26.7682. Epub 2010 Apr 12. J Clin Oncol. 2010. PMID: 20385980 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters